IGM Biosciences, Inc. Marketable Securities (Current)
IGM Biosciences, Inc. had Marketable Securities (Current) of $236.17 million as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet › Assets › Assets, Current › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2023-08-03
- 2023-06-30: Marketable Securities, Current $236.17M.
- 2023-03-31: Marketable Securities, Current $233.23M.
- 2022-12-31: Marketable Securities, Current $305.93M.
- 2022-09-30: Marketable Securities, Current $291.73M.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-06-30 | $236.17M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $233.23M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $305.93M 10-Q · filed 2023-08-03 |
| 2022-09-30 | $291.73M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $291.93M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $112.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $96.21M 10-K · filed 2023-03-30 |